CTOs on the Move

Access Integrated Healthcare

www.accessih.com

 
Founded by Chief Executive Officer Sam Solakyan, Global Holdings, Inc. has excelled in its journey in becoming leaders in each of the industries it has a presence in. Their main responsibility lies in providing their clients with the most premiere level of service. More than just your typical holdings group, Global is a multifaceted company with financial assets and ownership in the radiology, pharmaceuticals, and medical billing and collections industries. Instead of merely buying and selling companies like other holdings groups, Global searches for the less desirable companies with hidden potential and applies its knowledge and expertise in the management ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.accessih.com
  • 550 N. Brand Blvd. 20th Floor
    Glendale, CA USA 91203
  • Phone: 866.460.7465

Executives

Name Title Contact Details

Similar Companies

Lexicomm International

Lexicomm International, Ltd. is a Jenkintown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Coordinated Health Center

Coordinated Health Center is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PACS

Providence Administrative Consulting Services (PACS) provides administrative support services that elevate skilled nursing facilities, empowering and equipping local leadership teams to deliver excellent care and make positive contributions to their co...

United Methodist Communities

You will find comfort, security, and gracious services that exceed your expectations in our communities. A caring staff will provide thoughtful attention to your needs. Old friends will want to visit. New neighbors will welcome you. The amenities of shops, restaurants, entertainment, events and churches are readily accessible in town. Year after year, residents and staff award our communities the highest satisfaction ratings in an independent survey.

Metamark

Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.